Clinical Diagnostics Market in APAC - Market Analysis 2015-2019

アジアの臨床診断機器市場:免疫診断、POC診断、分子診断、血液科診断、組織検査、微生物検査

◆タイトル:Clinical Diagnostics Market in APAC - Market Analysis 2015-2019
◆商品コード:IRTNTR7299
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年10月7日
◆ページ数:64
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、アジアの臨床診断機器市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アジアの臨床診断機器市場規模及び予測、製品別分析、市場シェア、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・アジアの臨床診断機器市場:市場規模及び予測
・アジアの臨床診断機器市場:製品別分析
・アジアの臨床診断機器市場:成長要因
・アジアの臨床診断機器市場:課題
・市場シェア
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About clinical diagnostics
Clinical diagnostics or in-vitro diagnostics is a method to perform diagnostics tests by using instruments, assay reagents, and systems to diagnose a disease or medical condition in a laboratory. Early and accurate diagnosis of life-threatening diseases such as cancer, cardiovascular disease, and influenza will boost the sales of clinical diagnostics products. Factor such as a rapid increase in the number of people with diabetes in developing countries such as in India will increase the sales of diagnostics as there are 50 million diabetes patients. Diabetes can increase the risk of active TB, and this infection can worsen the blood glucose level. To handle this types of medical cases, rapid molecular TB diagnosis is done.

Technavio’s analysts forecast the clinical diagnostics market in APAC to grow at a CAGR of 12.90% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the clinical diagnostics market in APAC for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostic kits, instruments, and reagents:
• POC
• Tissue diagnostic
• Clinical microbiology
• Immunodiagnostics
• Molecular diagnostic
• Hematology

Technavio’s report, Clinical Diagnostics Market in APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC; it also covers the landscape of the clinical diagnostic market in APAC and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• Beckman Coulter Diagnostics
• Biomerieux
• Qiagen
• Roche

[Other prominent vendors]
• Amgenix International
• BD
• Cepheid
• DiagCor
• Hologic
• J. Mitra
• Landwind Medical
• Life Technologies
• Mindray
• Randox Laboratories
• Snibe Diagnostics
• Span Diagnostics
• Sysmex
• Tosoh
• Trivitron Healthcare
• URIT

[Market Driver]
• Early and accurate diagnosis of life-threatening diseases
• For a full, detailed list, view our report

[Market challenge]
• Lack of infrastructure and trained professionals
• For a full, detailed list, view our report

[Market trend]
• Privatization and healthcare coverage
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Impact of regulatory services
Impact of regulatory services on clinical diagnostic devices

PART 07: Clinical diagnostics: Product pipeline
Clinical diagnostics: Product pipeline

PART 08: Market segmentation by product
Immunodiagnostics market in APAC
POC diagnostics market in APAC
Molecular diagnostics market in APAC
Hematology devices market in APAC
Tissue diagnostics market in APAC
Clinical microbiology systems market in APAC

PART 09: Market drivers
Early and accurate diagnosis of life-threatening diseases
Market expansion
POC home diagnostics
Government funding
Domestic manufacturing of devices in China

PART 10: Impact of drivers

PART 11: Market challenges
Lack of infrastructure and skilled professionals
Issues with intellectual property rights
Availability of counterfeit IVD products
Inaccuracy of conventional diagnostics
Pricing policies and unfavorable reimbursement policies in China

PART 12: Impact of drivers and challenges

PART 13: Market trends
Privatization and healthcare coverage
Emergence of antibiotic-resistant pathogens
Personalized medicines
Next-generation technology and DNA microarrays
Local distributors as intermediaries

PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 15: Key vendor analysis
Abbott Diagnostics
bioMérieux
Beckman Coulter
Qiagen
Roche Diagnostics

PART 16: Appendix
List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Clinical diagnostics market in APAC 2014-2019 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Regulatory bodies and their policies for clinical diagnostic devices in APAC
Exhibit 05: Clinical diagnostics pipeline of various companies
Exhibit 06: Segmentation of clinical diagnostics market in APAC by product
Exhibit 07: Segmentation of clinical diagnostics market in APAC by product 2014
Exhibit 08: Immunodiagnostics market in APAC 2014-2019 ($ billions)
Exhibit 09: POC diagnostics market in APAC 2014-2019 ($ billions)
Exhibit 10: Molecular diagnostics market in APAC 2014-2019 ($ millions)
Exhibit 11: Hematology devices market in APAC 2014-2019 ($ billions)
Exhibit 12: Tissue diagnostics market in APAC 2014-2019 ($ millions)
Exhibit 13: Clinical microbiology systems market in APAC 2014-2019 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Abbott Diagnostics: Key takeaways
Exhibit 17: Beckman Coulter: Key takeaways
Exhibit 18: bioMérieux: Key takeaways
Exhibit 19: Qiagen: Key takeaways
Exhibit 20: Roche Diagnostics: Key takeaways



【掲載企業】

Abbott, Biomerieux, Beckman Coulter Diagnostics, Roche, Qiagen, Amgenix International, BD, Cepheid, DiagCor, Hologic, Life Technologies, J. Mitra & Co Pvt. Ltd, Landwind Medical, Mindray, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, Tosoh Corporation, URIT.

【資料のキーワード】

臨床診断機器、免疫診断、POC診断、分子診断、血液科診断、組織検査、微生物検査、検査装置、診断試薬、診断キット、アジア、医療デバイス

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[アジアの臨床診断機器市場:免疫診断、POC診断、分子診断、血液科診断、組織検査、微生物検査]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆